{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:35:54Z","timestamp":1790742954609,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2008,6,5]],"date-time":"2008-06-05T00:00:00Z","timestamp":1212624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1007\/s00702-008-0060-5","type":"journal-article","created":{"date-parts":[[2008,6,4]],"date-time":"2008-06-04T09:05:00Z","timestamp":1212570300000},"page":"1133-1139","source":"Crossref","is-referenced-by-count":15,"title":["Effect of locus coeruleus denervation on levodopa-induced motor fluctuations in hemiparkinsonian rats"],"prefix":"10.1007","volume":"115","author":[{"given":"C.","family":"Marin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bonastre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,6,5]]},"reference":[{"key":"60_CR1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0014-2999(76)90136-9","volume":"39","author":"N Anden","year":"1976","unstructured":"Anden N, Grabowska M (1976) Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur J Pharmacol 39:275\u2013282","journal-title":"Eur J Pharmacol"},{"key":"60_CR2","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/BF00449115","volume":"76","author":"T Archer","year":"1982","unstructured":"Archer T, Ogren SO, Johansson G, Ross SB (1982) DSP-4 induced two-active avoidance impairment in rats: involvement of central and not peripheral noradrenaline depletion. Psychopharmacology 76:303\u2013309","journal-title":"Psychopharmacology"},{"key":"60_CR3","first-page":"235","volume":"4","author":"T Archer","year":"2000","unstructured":"Archer T, Fredriksson A (2000) Effects of clonidine and alpha-adrenoreceptor antagonists on motor activity in DSP-4 treated mice: dose-, time- and parameter-dependency. Neurotox Res 4:235\u2013247","journal-title":"Neurotox Res"},{"key":"60_CR4","doi-asserted-by":"crossref","first-page":"9595","DOI":"10.1523\/JNEUROSCI.2583-07.2007","volume":"27","author":"P Belujon","year":"2007","unstructured":"Belujon P, Bezard E, Taupignon A, Bioulac B, Benazzouz A (2007) Noradrenergic modulation of subthalamic nucleus activity: behavioral and electrophysiological evidence in intact and 6-hydroxydopamine-lesioned rats. J Neurosci 27:9595\u20139606","journal-title":"J Neurosci"},{"key":"60_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0006-8993(94)90534-7","volume":"668","author":"G Bing","year":"1994","unstructured":"Bing G, Zhang Y, Watanabe T, McEven BS, Stone EA (1994) Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra. Brain Res 668:161\u2013165","journal-title":"Brain Res"},{"key":"60_CR6","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0006-8993(90)91087-W","volume":"513","author":"NS Canteras","year":"1990","unstructured":"Canteras NS, Shammah-Lagnado SJ, Silva BA, Ricardo JA (1990) Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat. Brain Res 513:43\u201359","journal-title":"Brain Res"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S0022-3565(24)38022-X","volume":"288","author":"P Chopin","year":"1999","unstructured":"Chopin P, Colpaert FC, Marien M (1999) Effects of alpha-2 adrenoreceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway. J Pharmacol Exp Ther 288:798\u2013804","journal-title":"J Pharmacol Exp Ther"},{"key":"60_CR8","first-page":"44","volume":"290","author":"GL Collingridge","year":"1979","unstructured":"Collingridge GL, James TA (1979) Neurochemical and electrophysiological evidence for a projection from the locus coeruleus to the substantia nigra. J Physiol 290:44","journal-title":"J Physiol"},{"key":"60_CR9","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0166-2236(90)90110-V","volume":"13","author":"MR DeLong","year":"1990","unstructured":"DeLong MR (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci 13:281\u2013285","journal-title":"Trends Neurosci"},{"key":"60_CR10","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/jnen\/61.5.413","volume":"61","author":"K Del Tredici","year":"2002","unstructured":"Del Tredici K, R\u00fcb U, De Vos RA, Bohl JR, Braak H (2002) Where does Parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 61:413\u2013426","journal-title":"J Neuropathol Exp Neurol"},{"key":"60_CR52","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","volume":"38","author":"H Ehringer","year":"1960","unstructured":"Ehringer H, Hornykiewicz O (1960) Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klin Wochenschr 38:1236\u20131239","journal-title":"Klin Wochenschr"},{"key":"60_CR11","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1097\/00001756-199412000-00045","volume":"5","author":"TM Engber","year":"1994","unstructured":"Engber TM, Papa SM, Boldry RC, Chase TN (1994) NMDA receptor blockade reverses motor response alterations induced by levodopa. Neuroreport 5:2586\u20132588","journal-title":"Neuroreport"},{"key":"60_CR12","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(95)00313-A","volume":"283","author":"F Fornai","year":"1995","unstructured":"Fornai F, Bassi L, Torracca MT, Scalori V, Corsini GU (1995) Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice. Eur J Pharmacol 283:99\u2013102","journal-title":"Eur J Pharmacol"},{"key":"60_CR13","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1006\/neur.1996.0032","volume":"5","author":"F Fornai","year":"1996","unstructured":"Fornai F, Bassi L, Torracca MT, Alessandri MG, Scalori V, Corsini GU (1996) Region-and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents. Neurodegeneration 5:241\u2013249","journal-title":"Neurodegeneration"},{"key":"60_CR14","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-3565(24)37011-9","volume":"283","author":"F Fornai","year":"1997","unstructured":"Fornai F, Alessandri MG, Torracca MT, Bassi L, Corsini GU (1997) Effects of noradrenergic lesions on MPTP\/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletion. J Pharmacol Exp Ther 283:100\u2013107","journal-title":"J Pharmacol Exp Ther"},{"key":"60_CR15","first-page":"1330","volume":"14","author":"F Fornai","year":"2007","unstructured":"Fornai F, di Poggio AB, Pellegrini A, Ruggieri S, Paprelli A (2007) Noradrenaline in Parinson\u2019s disease progression to current therapeutics. Curr Med Chem 14:1330\u20131334","journal-title":"Curr Med Chem"},{"key":"60_CR16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00005072-199603000-00001","volume":"55","author":"LS Forno","year":"1996","unstructured":"Forno LS (1996) Neuropathology of Parkinson\u2019s disease. J Neuropathol Exp Neurol 55:259\u2013272","journal-title":"J Neuropathol Exp Neurol"},{"key":"60_CR17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0306-4522(89)90364-3","volume":"30","author":"JM Fritschy","year":"1989","unstructured":"Fritschy JM, Grzanna R (1989) Immunohistochemical analysis of the neurotoxic effects of DSP-4 identifies two populations of noradrenergic axon terminals. Neuroscience 30:191\u2013197","journal-title":"Neuroscience"},{"key":"60_CR18","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0149-7634(00)00028-2","volume":"24","author":"M Gesi","year":"2000","unstructured":"Gesi M, Soldani P, Giorgi FS, Santiami A, Bonaccorsi I, Fornai F (2000) The role of the locus coeruleus in the development of Parkinson\u2019s disease. Neurosci Biobehav Rev 24:655\u2013668","journal-title":"Neurosci Biobehav Rev"},{"key":"60_CR19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01244934","volume":"93","author":"J Grenhoff","year":"1993","unstructured":"Grenhoff J, Nisell M, Ferr\u00e9 S, Aston-Jones G, Svensson TH (1993) Noradrenergic modulation of midbrain dopamine cell firing elicited by stimulation of the locus coeruleus in the rat. J Neural Transm Gen Sect 93:11\u201325","journal-title":"J Neural Transm Gen Sect"},{"key":"60_CR20","first-page":"19","volume":"45","author":"O Hornykiewicz","year":"1987","unstructured":"Hornykiewicz O, Kish SJ (1987) Biochemical pathophysiology of Parkinson\u2019s disease. Adv Neurol 45:19\u201334","journal-title":"Adv Neurol"},{"key":"60_CR21","first-page":"59","volume-title":"Noradrenergic mechanisms in Parkinson\u2019s disease","author":"O Hornykiewicz","year":"1994","unstructured":"Hornykiewicz O, Pifl C (1994) The validity of the MPTP primate model from neurochemical pathology of idiopathic Parkinson\u2019s disease. In: Briley M, Marien M (eds) Noradrenergic mechanisms in Parkinson\u2019s disease. CRC Press, Boca Raton, pp 59\u201371"},{"key":"60_CR22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1365-2680.1999.tb00003.x","volume":"19","author":"AL Hudson","year":"1999","unstructured":"Hudson AL, Robinson ES, Lalies MD, Tyacke RJ, Jackson HC, Nutt DJ (1999) In vitro and in vivo approaches to the characterization of the alpha2-adrenoreceptor. J Auton Pharmacol 19:311\u2013320","journal-title":"J Auton Pharmacol"},{"key":"60_CR23","first-page":"25","volume":"127","author":"BE Jones","year":"1977","unstructured":"Jones BE, Moore RY (1977) Ascending projections of the locus coeruleus in the rat. II. Autoradiographic study. Brain Res 127:25\u201353","journal-title":"Brain Res"},{"key":"60_CR53","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/cne.902420105","volume":"242","author":"BE Jones","year":"1985","unstructured":"Jones BE, Yang TZ (1985) The afferent projections from the reticular formation and the locus coeruleus studied by anterograde and retrograde axonal transport in the rat. J Comp Neurol 242:56\u201392","journal-title":"J Comp Neurol"},{"key":"60_CR24","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","volume":"392","author":"T Kitada","year":"1998","unstructured":"Kitada T, Asakawa S, Hattori N, Matsumune H, Yamamura Y, Minoshima S, Yokochi M, Mizuno Y, Shimizu N (1998) Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392:605\u2013608","journal-title":"Nature"},{"key":"60_CR25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1468-1331.2002.00346.x","volume":"9","author":"VS Kostic","year":"2002","unstructured":"Kostic VS, Marinkovic J, Svetel M, Stefanova E, Przedborski S (2002) The effect of stage of Parkinson\u2019s disease at the onset of levodopa therapy on development of motor complications. Eur J Neurol 9:9\u201314","journal-title":"Eur J Neurol"},{"key":"60_CR26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/0006-8993(90)91646-X","volume":"523","author":"AJ Lategan","year":"1990","unstructured":"Lategan AJ, Marien MR, Coalpaert FC (1990) Effects of locus coeruleus lesions on the release of endogenous dopamine in the rat nucleus accumbens and caudate nucleus as determined by intracerebral microdialysis. Brain Res 523:134\u2013138","journal-title":"Brain Res"},{"key":"60_CR27","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0024-3205(92)90093-5","volume":"50","author":"AJ Lategan","year":"1992","unstructured":"Lategan AJ, Marien MR, Colpaert FC (1992) Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study. Life Sci 50:995\u2013999","journal-title":"Life Sci"},{"key":"60_CR28","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0014-2999(93)90489-5","volume":"236","author":"M Marien","year":"1993","unstructured":"Marien M, Briley M, Colpaert E (1993) Noradrenaline depletion exacerbates MPTP-induced striatal dopamine loss in mice. Eur J Pharmacol 236:487\u2013489","journal-title":"Eur J Pharmacol"},{"key":"60_CR29","first-page":"127","volume-title":"Noradrenergic mechanisms in Parkinson\u2019s disease","author":"M Marien","year":"1994","unstructured":"Marien M, Lategan A, Colpaert F (1994) Noradrenergic control of striatal dopamine. In: Briley M, Marien M (eds) Noradrenergic mechanisms in Parkinson\u2019s disease. CRC Press, Boca Raton, pp 127\u2013138"},{"key":"60_CR30","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.brainresrev.2004.02.002","volume":"45","author":"MR Marien","year":"2004","unstructured":"Marien MR, Colpaert FC, Rosenquist AC (2004) Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Rev 45:38\u201378","journal-title":"Brain Res Rev"},{"key":"60_CR31","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/cne.901870405","volume":"187","author":"ST Mason","year":"1979","unstructured":"Mason ST, Fibiger HC (1979) Regional topography within noradrenergic locus coeruleus as revealed by retrograde transport of horseradish peroxidase. J Comp Neurol 187:703\u2013724","journal-title":"J Comp Neurol"},{"key":"60_CR32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0306-4522(91)90345-O","volume":"41","author":"M Mavridis","year":"1991","unstructured":"Mavridis M, Degryse AD, Lategan AJ, Marien MR, Colapert FC (1991) Effect of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson\u2019s disease. Neuroscience 41:507\u2013523","journal-title":"Neuroscience"},{"key":"60_CR33","first-page":"143","volume":"19","author":"H Narabayashi","year":"1983","unstructured":"Narabayashi H (1983) Pharmacological basis of akinesia in Parkinson\u2019s disease. J Neural Transm Suppl 19:143\u2013151","journal-title":"J Neural Transm Suppl"},{"key":"60_CR34","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/0304-3940(91)90941-L","volume":"123","author":"K Nishi","year":"1991","unstructured":"Nishi K, Kondo T, Narabayashi H (1991) Destruction of norepinephrine terminals in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-treated mice reduces locomotor activity induced by l-Dopa. Neurosci Lett 123:244\u2013247","journal-title":"Neurosci Lett"},{"key":"60_CR35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.410390504","volume":"39","author":"JG Nutt","year":"1996","unstructured":"Nutt JG, Holford NH (1996) The response to levodopa in Parkinson\u2019s disease imposing pharmacological law and order. Ann Neurol 39:561\u2013573","journal-title":"Ann Neurol"},{"key":"60_CR36","first-page":"159","volume-title":"Noradrenergic mechanisms in Parkinson\u2019s disease","author":"DJ Nutt","year":"1994","unstructured":"Nutt DJ, Lalies M, Hudson A (1994) The effects of alpha-2-adrenoreceptor antagonists on extracellular dopamine concentrations in the rat striatum. In: Colpaert F, Briley M (eds) Noradrenergic mechanisms in Parkinson\u2019s disease. Academic Press, New York, pp 159\u2013172"},{"issue":"10 Suppl","key":"60_CR37","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S1471-1931(00)00028-8","volume":"23","author":"JA Obeso","year":"2000","unstructured":"Obeso JA, Olanow CW, Nutt JG (2000) Levodopa motor complications in Parkinson\u2019s disease. Trends Neurosci 23(10 Suppl):S8\u2013S19","journal-title":"Trends Neurosci"},{"issue":"1 Suppl 1","key":"60_CR38","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1212\/WNL.62.1_suppl_1.S17","volume":"62","author":"JA Obeso","year":"2004","unstructured":"Obeso JA, Rodr\u00edguez-Oroz MC, Marin C, Alonso F, Zamarbide I, Lanciego JL, Rodr\u00edguez-D\u00edaz M (2004) The origin of motor fluctuations in Parkinson\u2019s disease: importance of dopaminergic innervation and basal ganglia circuits. Neurology 62(1 Suppl 1):S17\u2013S30","journal-title":"Neurology"},{"key":"60_CR39","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S1474-4422(06)70521-X","volume":"5","author":"CW Olanow","year":"2006","unstructured":"Olanow CW, Obeso JA, Stocchi F (2006) Continuous dopamine-receptor treatment of Parkinson\u2019s disease: scientific rationale and clinical implications. Lancet Neurol 5:677\u2013687","journal-title":"Lancet Neurol"},{"key":"60_CR40","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0006-8993(94)90796-X","volume":"662","author":"SM Papa","year":"1994","unstructured":"Papa SM, Engber TM, Kask AM, Chase TN (1994) Motor fluctuations in levodopa-treated parkinsonian rats: relation to lesion extent and treatment duration. Brain Res 662:69\u201374","journal-title":"Brain Res"},{"key":"60_CR41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0165-0173(94)00008-D","volume":"20","author":"A Parent","year":"1995","unstructured":"Parent A, Hazrati LN (1995) Functional anatomy of the basal ganglia. II. The place of subthalamic nucleus and external pallidum in basal ganglia circuitry. Brain Res Brain Res Rev 20:128\u2013154","journal-title":"Brain Res Brain Res Rev"},{"key":"60_CR42","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"1986","unstructured":"Paxinos G, Watson C. (1986) The rat brain in stereotaxic coordinates. Academic Press, New York"},{"key":"60_CR43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2007.08.024","volume":"576","author":"V P\u00e9rez","year":"2007","unstructured":"P\u00e9rez V, Sosti V, Rubio A, Barbanoj M, Rodr\u00edguez-\u00c1lvarez J, Kulisevsky J (2007) Modulation of the motor response to dopaminergic drugs in a parkinsonian model of combined dopaminergic and noradrenergic degeneration. Eur J Pharmacol 576:83\u201390","journal-title":"Eur J Pharmacol"},{"key":"60_CR44","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/0306-4522(91)90080-8","volume":"44","author":"C Pifl","year":"1991","unstructured":"Pifl C, Schingnitz G, Hornykiewicz O (1991) Effect of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey. Neuroscience 44:591\u2013605","journal-title":"Neuroscience"},{"key":"60_CR45","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bcp.2007.01.036","volume":"74","author":"KS Rommelfanger","year":"2007","unstructured":"Rommelfanger KS, Weinshenker D (2007) Norepimephrine: the redheaded stepchild of Parkinson\u2019s disease. Biochem Pharmacol 74:177\u2013190","journal-title":"Biochem Pharmacol"},{"key":"60_CR46","doi-asserted-by":"crossref","first-page":"13804","DOI":"10.1073\/pnas.0702753104","volume":"104","author":"KS Rommelfanger","year":"2007","unstructured":"Rommelfanger KS, Edwards GL, Freeman KG, Liles LC, Miller GW, Weinshenker D (2007) Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice. Proc Natl Acad Sci USA 104:13804\u201313809","journal-title":"Proc Natl Acad Sci USA"},{"key":"60_CR47","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1046\/j.1460-9568.2003.02684.x","volume":"17","author":"J Srinivasan","year":"2003","unstructured":"Srinivasan J, Schmidt WJ (2003) Potentiation of parkinsonian symptoms by depletion of locus coeruleus noradrenaline in 6-hydroxydopamine-induced partial degeneration of substantia nigra in rats. Eur J Neurosci 17:2586\u20132592","journal-title":"Eur J Neurosci"},{"key":"60_CR48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00702-003-0062-2","volume":"111","author":"J Srinivasan","year":"2004","unstructured":"Srinivasan J, Schmidt WJ (2004) Functional recovery of locus coeruleus noradrenergic neurons after DSP-4 lesion: effects on dopamine levels and neuroleptic induced-parkinsonian symptoms in rats. J Neural Transm 111:13\u201326","journal-title":"J Neural Transm"},{"key":"60_CR49","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.nbd.2006.12.021","volume":"26","author":"B Thomas","year":"2007","unstructured":"Thomas B, von Coelln R, Mandir AS, Trinkaus DB, Farah MH, Lim KL, Calingasan NY, Beal MF, Dawson VL, Dawson TM (2007) MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity. Neurobiol Dis 26:312\u2013322","journal-title":"Neurobiol Dis"},{"key":"60_CR50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","volume":"60","author":"C Zarow","year":"2007","unstructured":"Zarow C, Lyness SA, Mortimer JA, Chui HC (2007) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson\u2019s disease. Arch Neurol 60:337\u2013341","journal-title":"Arch Neurol"},{"key":"60_CR51","doi-asserted-by":"crossref","first-page":"13354","DOI":"10.1073\/pnas.240347797","volume":"97","author":"Y Zhang","year":"2000","unstructured":"Zhang Y, Gao J, Chung KK, Huang H, Dawson VL, Dawson TM (2000) Parkin functions as an E2-dependent ubiquitin\u2013protein ligase and promotes the degradation of the synpatic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci USA 97:13354\u201313359","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0060-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-008-0060-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-008-0060-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T15:20:12Z","timestamp":1738250412000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-008-0060-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,5]]},"references-count":53,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s00702-008-0060-5","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,5]]}}}